SURROZEN, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.2 USD | -5.64% |
|
-18.94% | -2.13% |
| Apr. 10 | Surrozen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Apr. 08 | Surrozen Insider Bought Shares Worth $2,999,994, According to a Recent SEC Filing | MT |
Chart calendar Surrozen, Inc.
8055835478c8bf9a33977a5d7da2cd2.fv_LHgk85HjQRa3qL8ZAjwv6LZ1px8QDX4HFCsCmdMk.JM6MU2ZK1T-dHO-1WrwK-XGKGvwxopJvMMmtTYzIMJooy75oO2_JNoA2yg~4b8962410736d90bbd9e2cc1c2eaf55a
Upcoming events on Surrozen, Inc.
Past events on Surrozen, Inc.
| 2024-03-20 | Q4 2023 Earnings Release (Projected) |
| 2023-12-07 01:00 pm | Extraordinary Shareholders Meeting |
| 2023-11-08 04:05 pm | Q3 2023 Earnings Release |
| 2023-08-09 04:05 pm | Q2 2023 Earnings Release |
| 2023-05-18 01:00 pm | Annual General Meeting |
| 2023-05-10 04:05 pm | Q1 2023 Earnings Release |
| 2023-03-22 04:30 pm | Business Update Call |
| 2023-03-22 04:01 pm | Q4 2022 Earnings Release |
| 2023-01-12 10:30 am | JP Morgan Healthcare Conference |
| 2022-11-14 04:30 pm | Q3 2022 Earnings Release |
| 2022-08-11 08:00 am | Interim 2022 Earnings Release |
| 2022-06-07 02:00 pm | Annual General Meeting |
| 2022-05-11 07:00 pm | Bank of America Healthcare Conference |
| 2022-05-11 08:00 am | Q1 2022 Earnings Release |
| 2022-04-30 | Association for Research in Vision and Ophthalmology Meeting |
| 2022-03-24 08:00 am | FY 2021 Earnings Release |
| 2022-01-13 09:00 am | JP Morgan Healthcare Conference |
| 2021-11-22 10:00 am | Piper Sandler Virtual Healthcare Conference |
| 2021-11-16 04:40 pm | Stifel Healthcare Conference |
| 2021-11-15 04:00 pm | Q3 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 12,5 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -52,3 -52,1 -0.5% | -42,4 -52,9 19.84% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -54,4 -53,9 -0.97% | -44,3 -55,4 20.03% | -45,8 -45,1 -1.51% | -27,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -54,6 -53,8 -1.58% | -36,0 -48,4 25.61% | -43,0 -43,1 0.13% | -18,0 |
|
Net income Million USD | Released Forecast Spread | -32,7 | -54,6 -54,1 -1.09% | -36,0 -50,3 28.37% | -43,0 -43,2 0.25% | -27,2 |
|
EPS USD | Released Forecast Spread | -66,3 | -33,1 -34,5 3.91% | -15,6 -21,6 27.62% | -21,3 -18,2 -17.04% | -7,28 |
| Announcement Date | 14/05/21 | 24/03/22 | 22/03/23 | 10/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 12,5 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -15,0 -14,5 -3.64% | -14,5 -15,7 7.78% | -14,1 -16,1 12.83% | -13,6 -15,3 10.84% | -2,17 -13,2 83.56% | -14,6 -13,2 -10.27% | -10,3 -12,5 17.8% | -11,2 -9,05 -23.64% | -9,72 -9,00 -8.04% | -9,05 | -9,05 | -9,05 | -9,05 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,0 -14,1 -6.06% | -7,95 -15,2 47.72% | -13,9 -16,8 16.87% | -13,4 -15,0 10.95% | -0,78 -13,3 94.17% | -14,3 -12,2 -17.19% | -9,39 -12,8 26.66% | -10,4 -9,40 -11.12% | -8,91 -9,00 0.97% | -9,00 | -9,00 | -9,00 | -9,00 | |
|
Net income Million USD | Released Forecast Spread | -15,0 -14,4 -4.19% | -7,95 -15,4 48.29% | -13,9 -16,2 13.9% | -13,4 -15,3 12.6% | -0,78 -15,0 94.84% | -14,3 -12,5 -14.07% | -9,39 -12,5 24.9% | -10,4 -9,05 -15.41% | -8,91 -9,00 0.97% | -9,05 | -9,05 | -9,05 | -9,05 | |
|
EPS USD | Released Forecast Spread | -5,25 -6,90 23.91% | -3,45 -7,88 56.19% | -6,00 -6,85 12.41% | -5,70 -6,40 10.94% | -0,45 -6,41 92.98% | -7,20 -5,56 -29.49% | -4,65 -6,15 24.39% | -5,10 -4,43 -15.25% | -4,38 -3,00 -46% | -2,95 | -2,19 | -2,15 | -1,81 | |
| Announcement Date | 24/03/22 | 11/05/22 | 11/08/22 | 14/11/22 | 22/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 10/04/24 | - | - | - | - | - |
More events
Past sector events for Surrozen, Inc.
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
| 2024-03-27 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q4 2023 Earnings Release |
| 2024-03-27 10:25 am | PHARMARON BEIJING CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SRZN Stock
- Calendar Surrozen, Inc.
